{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:13:14Z","timestamp":1770916394466,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bone.2022.116477","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T02:31:45Z","timestamp":1656469905000},"page":"116477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-1546","authenticated-orcid":false,"given":"Roland","family":"Kocijan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Stockinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-6785","authenticated-orcid":false,"given":"Judith","family":"Haschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-7482","authenticated-orcid":false,"given":"Berthold","family":"Reichardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-1876","authenticated-orcid":false,"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5449-0223","authenticated-orcid":false,"given":"Martina","family":"Behanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2022.116477_bb0005","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00198-020-05793-3","article-title":"How has COVID-19 affected the treatment of osteoporosis?An IOF-NOF-ESCEO global survey","volume":"32","author":"Fuggle","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-020-05722-4","article-title":"A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic","volume":"32","author":"Sapkota","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00198-020-05542-6","article-title":"Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures","volume":"32","author":"McCloskey","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2022.116477_bb0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00198-021-05882-x","article-title":"Virtual fracture liaison clinics in the COVID era: an initiative to maintain fracture prevention services during the pandemic associated with positive patient experience","volume":"32","author":"English","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116477_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2022.116477_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2022.116477_bb0040","article-title":"Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia","volume":"1\u201311","author":"Chandran","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11657-021-00904-x","article-title":"Poor adherence to parenteral osteoporosis therapies during COVID-19 pandemic","volume":"16","author":"Kocijan","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bone.2022.116477_bb0050","series-title":"Health and Consumer Protection. The Austrian Health Care System. Key Facts. Vienna","year":"2019"},{"key":"10.1016\/j.bone.2022.116477_bb0055","series-title":"AGES COVID19 Dashboard","year":"2022"},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-021-01235-8","article-title":"Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions","volume":"21","author":"Schaffer","year":"2021","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.bone.2022.116477_bb0065","series-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"issue":"36","key":"10.1016\/j.bone.2022.116477_bb0070","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.bone.2022.116477_bb0075","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jbmr.4304","article-title":"Vaccination for coronavirus disease 2019 (COVID-19) and relationship to osteoporosis care: current evidence and suggested approaches","volume":"36","author":"Tsourdi","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2022.116477_bb0080","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jbmr.4419","article-title":"The use of oral amino-bisphosphonates and coronavirus disease 2019 (COVID-19) outcomes","volume":"36","author":"Luca Degli Esposti","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2022.116477_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12020-020-02500-4","article-title":"Are women with osteoporosis treated with denosumab at risk of severe COVID-19?","volume":"70","author":"Formenti","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.bone.2022.116477_bb0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-021-06067-2","article-title":"No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study","volume":"33","author":"Atmaca","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"20","key":"10.1016\/j.bone.2022.116477_bb0095","doi-asserted-by":"crossref","first-page":"19923","DOI":"10.18632\/aging.104117","article-title":"Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions","volume":"12","author":"Blanch-Rubio","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.bone.2022.116477_bb0100","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00198-021-05836-3","article-title":"COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey","volume":"32","author":"Singer","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1370\/afm.2731","article-title":"Impact of the COVID-19 pandemic on primary health care disease incidence rates: 2017 to 2020","volume":"20","author":"Siso-Almirall","year":"2021","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.bone.2022.116477_bb0110","first-page":"2593","article-title":"Preventive steps implemented on geriatric services in the primary health care centers during COVID-19 pandemic","volume":"11","author":"Alshaali","year":"2021","journal-title":"J. Public Health Res."},{"issue":"7","key":"10.1016\/j.bone.2022.116477_bb0115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00198-020-05413-0","article-title":"Osteoporosis in the age of COVID-19","volume":"31","author":"Girgis","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2022.116477_bb0120","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00198-020-05465-2","article-title":"Identifying and managing osteoporosis before and after COVID-19: rise of the remote consultation?","volume":"31","author":"Paskins","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2022.116477_bb0125","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-049972","article-title":"Prescription drug dispensing to US children during the COVID-19 pandemic","volume":"148","author":"Chua","year":"2021","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.bone.2022.116477_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061260","article-title":"Impact of the 1st and 2nd wave of the COVID-19 pandemic on primary or revision total hip and knee arthroplasty-a cross-sectional single center study","volume":"10","author":"Simon","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.bone.2022.116477_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11657-020-00869-3","article-title":"Joint position statement on management of patient with osteoporosis during COVID-19 contingency from the AMMOM, CONAMEGER, FELAEN, FEMECOG, FEMECOT, and ICAAFYD","volume":"16","author":"Torres-Naranjo","year":"2021","journal-title":"Arch. Osteoporos."},{"issue":"12","key":"10.1016\/j.bone.2022.116477_bb0140","first-page":"e4795","article-title":"Challenges and opportunities for osteoporosis care during the COVID-19 pandemic","volume":"106","author":"Cromer","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2022.116477_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00223-021-00858-9","article-title":"Diagnosis and management of osteoporosis during COVID-19: systematic review and practical guidance","volume":"109","author":"Hampson","year":"2021","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.bone.2022.116477_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.11005\/jbm.2021.28.2.115","article-title":"The impact of COVID-19 on the optimal management of osteoporosis","volume":"28","author":"Kong","year":"2021","journal-title":"J. Bone Metab."},{"issue":"2","key":"10.1016\/j.bone.2022.116477_bb0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00198-020-05557-z","article-title":"The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study","volume":"32","author":"McCloskey","year":"2021","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2022.116477_bb2000","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bone.2022.116477_bb3000","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1714350","article-title":"COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure","volume":"120","author":"Spiezia","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bone.2022.116477_bb4000","author":"COVID-19 Treatment Guidelines Panel"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328222001545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:02:57Z","timestamp":1757613777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328222001545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":33,"alternative-id":["S8756328222001545"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2022.116477","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2022.116477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116477"}}